Scientists have reported results from an early-stage trial of an immunotherapy drug called VIR-5500. The drug offers new hope for men with advanced prostate cancer who have stopped responding to other ...

In a study of adults with advanced prostate cancer taking androgen-receptor pathway inhibitors and different types of ...

One type of androgen deprivation therapy may speed coronary plaque growth in men being treated for localized prostate cancer.

Learn the key warning signs of prostate cancer that men often overlook. Early awareness can make all the difference.

The average age of men who get diagnosed is 67.

Former President Joe Biden was diagnosed with an “aggressive form” of prostate cancer that has a five-year survival rate of between 30% and 40%. The former president’s prostate cancer is characterized ...

People who have received a cancer diagnosis are living longer than ever, according to a new report from the American Cancer Society (ACS). Decades of cancer research have led to more effective ...

Men with prostate cancer who were treated with the GnRH agonist leuprolide had significantly more coronary artery plaque progression than those receiving the GnRH antagonist relugolix.

Scientists at NYU Langone Health examined cancerous and benign tissues from 10 patients with prostate cancer and found “small fragments of plastic” in both — but the tumors had much higher ...

In a study of adults with advanced prostate cancer taking androgen-receptor pathway inhibitors and different types of ...